U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681024) titled 'Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW)' on June 26.
Brief Summary: Global Registry study
Study Start Date: June 15
Study Type: OBSERVATIONAL
Condition:
Diabetes
Intervention:
DEVICE: Dexcom CGM (Continuous Glucose Monitor)
Use Dexcom CGM according to approved commercial use. Evaluate HbA1c over time.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: DexCom, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....